Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Are the Key Milestones in the Gastric Cancer Market’s Growth Trajectory From 2025 To 2034?

The market size for gastric cancer has been expanding swiftly over the past few years. The expectation is for it to escalate from $3.17 billion in 2024 to $3.65 billion in 2025, with a compound annual growth rate (CAGR) of 15.4%. The notable growth during the historical period is linked to the surge in the elderly population, heightened healthcare awareness, the rise of genetic mutations, increased adoption of unhealthy lifestyles and growing consciousness about cancer.

The market size for gastric cancer is predicted to experience a swift expansion in the forthcoming years. The market value is set to reach $6.43 billion by 2029, with a compound annual growth rate (CAGR) of 15.2%. This growth in the predicted period can be accredited to factors such as rising obesity rates, enhancement in government initiatives, amplified investments in healthcare, a surge in demand for oral medication, an increment in cancer treatment facilities. Key trends expected during the forecast period are combination chemotherapy, product enlargement, robotic-aided surgeries, targeted treatment methods, strategic cooperation, and sophisticated diagnostic tools.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20797&type=smp

Which Factors and External Forces Are Driving Demand in the Gastric Cancer Market?

The escalating numbers of obesity is predicted to amplify the expansion of the gastric cancer market moving forward. Obesity, a health disorder marked by excessive accumulation of body fat, often identified by a body mass index (BMI) of 30 or above, can lead to numerous health complications. The increasing prevalence of obesity can be attributed to reasons such as unhealthy food habits, inadequate physical exercise, sedentary way of life, environmental factors, and genetic influences. Excessive body fat, specifically visceral fat around the belly, is related to a heightened risk of gastric cancer as it instigates chronic inflammation and metabolic disturbances, both associated with cancer formation, contributing to a surge in the demand for gastric cancer therapy. For example, in March 2024, the World Health Organization, an Intergovernmental organization based in Switzerland, reported that nearly 1 in 8 individuals worldwide were obese in 2022, with around 2.5 billion adults over the age of 18 characterized as overweight, which includes around 890 million persons with obesity. In adults, 43% were overweight, and 16% were obese. Moreover, 37 million children under 5 were overweight, while over 390 million children and teenagers between 5 and 19 years were overweight or obese, which included 160 million living with obesity. Hence, the upward trend in obesity rates is influencing the growth of the gastric cancer market.

Which Segments in the Gastric Cancer Offer the Most Growth?

The gastric cancer market covered in this report is segmented –

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis

3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments

4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma

2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma

3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST

4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3

5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20797&type=smp

What Are the Fastest-Growing Geographies in the Gastric Cancer Market?

North America was the largest region in the gastric cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Gastric Cancer Market?

Leading enterprises in the gastric cancer market are striving to create state-of-the-art solutions like companion diagnostic assays. These are aimed at personalizing treatment by helping to pinpoint those who would gain the most from a specific therapy, based on particular biomarkers. An illustration is the announcement by Switzerland’s F. Hoffmann-La Roche Ltd., in October 2024, of their regulatory approval by the U.S. FDA for the VENTANA CLDN18 (43-14A) RxDx Assay. This is the inaugural immunohistochemistry (IHC) companion diagnostic for assessing CLDN18 protein expression in gastric and gastroesophageal junction (GEJ) adenocarcinoma. The assay spots patients eligible for targeted VYLOY (zolbetuximab) treatment as it measures CLDN18 protein variants, especially CLDN18.2. The test, which uses the OptiView DAB IHC Detection Kit on the BenchMark ULTRA device, furthers personalized healthcare and widens therapy alternatives for gastric and GEJ adenocarcinoma.

View the full report here:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

What Are the Key Elements That Define the Gastric Cancer Market?

Gastric cancer is a malignant tumor that originates in the lining of the stomach. It often begins in the mucosa, the innermost layer of the stomach, and can spread to deeper layers, nearby tissues, or distant organs if not treated early. The disease is commonly associated with risk factors such as chronic infection with helicobacter pylori, smoking, excessive alcohol consumption, poor diet, and genetic predisposition.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20797

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model